75 related articles for article (PubMed ID: 20483772)
1. Identification of Complin, a novel complement inhibitor that targets complement proteins factor B and C2.
Kadam AP; Sahu A
J Immunol; 2010 Jun; 184(12):7116-24. PubMed ID: 20483772
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
3. CRIT peptide interacts with factor B and interferes with alternative pathway activation.
Hui KM; Magnadóttir B; Schifferli JA; Inal JM
Biochem Biophys Res Commun; 2006 May; 344(1):308-14. PubMed ID: 16600177
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning, structural analysis and expression of complement component Bf/C2 genes in the nurse shark, Ginglymostoma cirratum.
Shin DH; Webb B; Nakao M; Smith SL
Dev Comp Immunol; 2007; 31(11):1168-82. PubMed ID: 17482263
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of chicken factor B-like protease and comparison with mammalian complement proteins factor B and C2.
Kjalke M; Welinder KG; Koch C
J Immunol; 1993 Oct; 151(8):4147-52. PubMed ID: 8409391
[TBL] [Abstract][Full Text] [Related]
6. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
[TBL] [Abstract][Full Text] [Related]
7. The secondary structure of the von Willebrand factor type A domain in factor B of human complement by Fourier transform infrared spectroscopy. Its occurrence in collagen types VI, VII, XII and XIV, the integrins and other proteins by averaged structure predictions.
Perkins SJ; Smith KF; Williams SC; Haris PI; Chapman D; Sim RB
J Mol Biol; 1994 Apr; 238(1):104-19. PubMed ID: 8145250
[TBL] [Abstract][Full Text] [Related]
8. Metal-dependent conformational changes in a recombinant vWF-A domain from human factor B: a solution study by circular dichroism, fourier transform infrared and (1)H NMR spectroscopy.
Hinshelwood J; Perkins SJ
J Mol Biol; 2000 Apr; 298(1):135-47. PubMed ID: 10756110
[TBL] [Abstract][Full Text] [Related]
9. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.
Hui KM; Orriss GL; Schirmer T; Magnadóttir B; Schifferli JA; Inal JM
Biochem J; 2005 Aug; 389(Pt 3):863-8. PubMed ID: 15823096
[TBL] [Abstract][Full Text] [Related]
10. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
11. Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
Sundsmo JS; Wood LM
J Immunol; 1981 Sep; 127(3):877-80. PubMed ID: 6911148
[TBL] [Abstract][Full Text] [Related]
12. Substituted isocoumarins as inhibitors of complement serine proteases.
Kam CM; Oglesby TJ; Pangburn MK; Volanakis JE; Powers JC
J Immunol; 1992 Jul; 149(1):163-8. PubMed ID: 1607651
[TBL] [Abstract][Full Text] [Related]
13. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
14. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
[TBL] [Abstract][Full Text] [Related]
15. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
16. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
Sobel AT; Cooper NR; Schreiber RD
J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the complement control protein modules of C2 in C4b binding assessed by analysis of C2/factor B chimeras.
Xu Y; Volanakis JE
J Immunol; 1997 Jun; 158(12):5958-65. PubMed ID: 9190950
[TBL] [Abstract][Full Text] [Related]
18. Cloning and molecular characterization of two complement Bf/C2 genes in large yellow croaker (Pseudosciaena crocea).
Wei W; Wu H; Xu H; Xu T; Zhang X; Chang K; Zhang Y
Fish Shellfish Immunol; 2009 Aug; 27(2):285-95. PubMed ID: 19490942
[TBL] [Abstract][Full Text] [Related]
19. Effect of histamine on monocyte complement production. II. Modulation of protein secretion, degradation and synthesis.
Lappin D; Moseley HL; Whaley K
Clin Exp Immunol; 1980 Dec; 42(3):515-22. PubMed ID: 7011615
[TBL] [Abstract][Full Text] [Related]
20. Studies of structure-activity relations of complement inhibitor compstatin.
Soulika AM; Morikis D; Sarrias MR; Roy M; Spruce LA; Sahu A; Lambris JD
J Immunol; 2003 Aug; 171(4):1881-90. PubMed ID: 12902490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
